First cabotegravir products prequalified
M
Past News
First primaquine prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Zydus’ daclatasvir products prequalified
M
WHO Prequalification Unit (PQT) added the below new products to its prequalified list:
Svizera’s isoniazid 300 mg tabl prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Aurobindo’s molnupiravir prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Zhejiang Huahai’s nirmatrelvir + ritonavir prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Shouguang Fukang’s sulfamethoxazole/trimetoprim tablets prequalified
M
WHO Prequalification Unit (PQT) added the below new products to its prequalified list:
Cipla’s molnupiravir prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
S Kant’s pyridoxine tablet prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequal
First products for Ebola Virus Disease prequalified
M
WHO Prequalification Unit (PQT) added the below new products to its prequalified list:
First bedaquiline product prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
- TB396 - Bedaquiline fumarate - 100mg - Tablet - Lupin Ltd - INDIA
First paediatric abacavir/dolutegravir/lamivudine 60mg/5mg/30mg dispersible tablet prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequal
Zhejiang Apeloa Kangyu’s nirmatrelvir + ritonavir tablet prequalified
M
WHO Prequalification Unit (PQT) added the below new products to its prequalified list:
Vaccines prequalification prioritity list 2024-2026
V
For more information click here
10th Invitation to manufacturers of reproductive health products to submit an expression of interest (EOI) for product evaluation to the WHO Prequalification Team: medicines
M
Addition:
Under section: 9. Antifibrinolytics
22nd Invitation for Expression of Interest (EOI) to manufacturers of antimalarial medicines published
M
New Invitation for Expression of Interest (EOI) to manufacturers of antimalarial medicines published
Addition:
Newly prequalified Active Pharmaceutical Ingredient (API)
M
Molnupiravir (WHOAPI-449) manufactured by Shanghai Desano Chemical Pharmac
Newly prequalified Active Pharmaceutical Ingredient (API)
M
Molnupiravir (WHOAPI-438) manufactured by Optimus Drugs Pvt Ltd, has been
Huayi’s sulfamethoxazole/trimethoprim tablets prequalified
M
WHO Prequalification Unit (PQT) added the below new products to its prequa
WHO Prequalification Team - Medicines (PQT/MED) has issued new guidance on the recommended style to be used for visual description of oral dosage forms in WHO Public Assessment Reports (WHOPARs)
M
WHO Prequalification Team - Medicines (PQT/MED) has issued a new guidance on the recommended style to be used for visual description of oral dosage forms in WHO Public Assessment Reports
Beijing Holley-Cotec’s DHA/piperaquine tablet prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Celltrion’s nirmatrelvir + ritonavir tablet prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Update on N-nitrosamine impurities
M
Applicants are reminded of the latest N-nitrosamines assessment policies for active pharmaceutical ingredients (APIs) and finished pharmaceutical products (FPPs):
Newly prequalified Active Pharmaceutical Ingredient (API)
M
Nirmatrelvir (WHOAPI-469) manufactured by Shanghai Desano Chemical Pharmaceutical Co Ltd, has been prequalified by the WHO Prequalification Team: Medicines under its API prequalification procedure.
Ipca’s higher strength artesunate injection prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
First rifapentine generic prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Micro Labs’ paediatric linezolid tablet prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Laurus’ atazanavir/ritonavir tablet prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Micro Labs’ lopinavir/ritonavir, including paediatric tablet, prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Human Insulin Master File (h-IMF)
M
Diabetes mellitus is a public health challenge due to its high and increasing prevalence and associated morbidity and mortality that have health and economic impact on ind